Navigation Links
Children's HIV Drugs May Cause High Cholesterol
Date:8/5/2011

FRIDAY, Aug. 5 (HealthDay News) -- Children with HIV who receive antiretroviral treatments have persistently high cholesterol and other blood fat (lipid) levels, and would benefit from guidelines aimed at reducing their long-term heart risks, researchers say.

The findings are published in JAIDS: Journal of Acquired Immune Deficiency Syndromes.

"Formal guidelines are the first crucial step in minimizing cardiovascular disease complications and maximizing quality of life in this vulnerable population," the authors of an editorial said in a journal news release. The most effective strategy probably consists of a "lipid-friendly" drug regimen -- meaning medications that don't affect blood fats -- along with lifestyle changes, such as diet and exercise, they said.

The editorial accompanies two studies in the Aug. 15 issue that examined blood fats in children treated for HIV.

In one study, led by Denise L. Jacobson of Harvard School of Public Health, the researchers followed 240 HIV-infected children with high cholesterol for two years. During this time, the children had persistently high lipid levels. Cholesterol levels dropped to normal in only about one-third of the children.

Cholesterol levels were more likely to decline when changes were made to their antiretroviral treatment, the researchers found. In most cases, medication changes were related to the HIV, not lipid levels. Only 15 of the children were given drugs specifically to manage their cholesterol.

In a separate study, researchers at the Imperial College School of Medicine, London, compared the effect of different HIV drugs on 449 HIV-infected children's lipid levels. They found all of the drugs caused a surge in cholesterol. The class of HIV drugs known as protease inhibitors, in particular, triggered the biggest increase.

Within five years, 10 percent of children developed low-density lipoprotein ("bad") cholesterol levels above the 95th percentile. But based on those numbers, only three patients needed to take cholesterol medication.

Because HIV-infected children are likely to live well into adulthood, the researchers said treatment strategies need to be developed that will protect them against heart disease later in life.

"Clinical trials are required to develop and test intervention strategies to protect against cardiovascular disease in children born with HIV, growing into adult life," Dr. Margaret P. Rhoads of Imperial College and co-authors wrote in the news release.

More information

The U.S. Centers for Disease Control and Prevention provides statistics on HIV/AIDS among children.

-- Mary Elizabeth Dallas

SOURCE: JAIDS: Journal of Acquired Immune Deficiency Syndromes, news release, Aug. 3, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Researcher at Childrens Hospital LA discovers way to overcome radiation resistance in leukemia
2. Parents Want Electronic Access to Their Childrens Docs: Survey
3. Cholesterol-lowering drugs may help prevent recurrent strokes in younger people
4. Are Newer MS Drugs Worth Their High Price Tag?
5. Cancer drugs may help treatment of schizophrenia
6. New mouse model for testing cancer drugs
7. Drugs Can Bring HIV-Infected Africans Normal Life Spans
8. UNC receives NIH grant to develop and test new drugs to block HIV infection
9. Drugs May Prevent HIV Spread Among Heterosexuals
10. Generic, Brand-Name Heart Drugs Seem to Have Same Effect on Thyroid
11. The metabolic effects of antipsychotic drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Children's HIV Drugs May Cause High Cholesterol
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps ... in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally ... one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... search for and donate to Give To Cure’s campaign that is crowdfunding clinical trials ... users make and share payments through a smart device. In 2015 alone, Venmo processed ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Dr. Justin ... announce their 2nd Annual No Cost Dental Day to individuals in need. The event ... purpose of this No Cost Dental Day is to provide dental care to community ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... DIEGO, Feb. 4, 2016  Aethlon Medical, Inc. ... affinity biofiltration devices to treat life-threatening diseases, today ... 2016 ended December 31, 2015. ... objectives set forth in our last quarterly call, ... reinforce our long-term objective to establish the Aethlon ...
Breaking Medicine Technology: